Skip to search formSkip to main contentSkip to account menu

methylprednisolone aceponate

Known as: 6alpha-methylprednisolone aceponate 
National Institutes of Health

Related topics

Related topics

6 relations

Narrower (2)

AdvantanLexxema

Broader (2)

Anti-Inflammatory AgentsMethylprednisolone
analogs & derivativescytochrome P450 3A4 protein, human

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Dr Michaels® product family (also branded as Soratinex®) versus Methylprednisolone aceponate - a comparative study of the effectiveness for the treatment of plaque psoriasis.
As one of the most common dermatologic chronic-recurrent disease, variable therapeutic options are available today for management… 
2010
2010
Improving the ex vivo stability of drug ester compounds in rat and dog serum: inhibition of the specific esterases and implications on their identity.
2009
2009
Bortezomib induces erythema multiforme-like cutaneous adverse effects: report of two cases
2007
2007
Superior nuclear receptor selectivity and therapeutic index of methylprednisolone aceponate versus mometasone furoate
Abstract: Although introduced more than 50 years ago, topical glucocorticoids are still the first line therapy for many… 
1994
1994
Preclinical evaluation of a new topical corticosteroid methylprednisolone aceponate
Objective: Preclinical characterization of methylprednisolone aceponate. 
1994
1994
Clinical comparison of methylprednisolone aceponate and prednicarbate in chronic eczema
Methylprednisolone aceponate (MPA) is a new topical corticosteroid developed specifically for the treatment of eczematous… 
1993
1993
Activity of topically applied methylprednisolone aceponate in relation to other topical glucocorticosteroids in healthy volunteers.
Topical glucocorticosteroids are useful in the treatment of various skin diseases. Although there are already many… 
1992
1992
Safety aspects of topical methylprednisolone aceponate (MPA) treatment
Many side effects, both local or systemic, may result from topical steroid therapy, especially after long-lasting treatment with… 
Review
1992
Review
1992
Methylprednisolone aceponate (MPA)* — a new therapeutic for eczema: A pharmacological overview
Advantan* is a new potent corticoid preparation that has been specially developed for the local treatment of eczematous… 
1992
1992
Methylprenisolone aceponate (MPA)* — use and clinical experience in children
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)